DK3285787T3 - Behandling af bakterieinfektioner i akvakultur - Google Patents
Behandling af bakterieinfektioner i akvakultur Download PDFInfo
- Publication number
- DK3285787T3 DK3285787T3 DK16720752.1T DK16720752T DK3285787T3 DK 3285787 T3 DK3285787 T3 DK 3285787T3 DK 16720752 T DK16720752 T DK 16720752T DK 3285787 T3 DK3285787 T3 DK 3285787T3
- Authority
- DK
- Denmark
- Prior art keywords
- aquaculture
- treatment
- bacterial infections
- infections
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15164343 | 2015-04-20 | ||
PCT/EP2016/058809 WO2016170013A1 (en) | 2015-04-20 | 2016-04-20 | Treatment of bacterial infections in aquaculture |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3285787T3 true DK3285787T3 (da) | 2020-05-18 |
Family
ID=52997913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16720752.1T DK3285787T3 (da) | 2015-04-20 | 2016-04-20 | Behandling af bakterieinfektioner i akvakultur |
Country Status (11)
Country | Link |
---|---|
US (1) | US10849942B2 (da) |
EP (1) | EP3285787B8 (da) |
KR (1) | KR20180016360A (da) |
CN (1) | CN107743397B (da) |
BR (1) | BR112017022463B1 (da) |
CA (1) | CA2983214C (da) |
CL (1) | CL2017002668A1 (da) |
DK (1) | DK3285787T3 (da) |
ES (1) | ES2790635T3 (da) |
PT (1) | PT3285787T (da) |
WO (1) | WO2016170013A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL416716A1 (pl) * | 2016-04-03 | 2017-10-09 | Proteon Pharmaceuticals Spółka Akcyjna | Szczepy bakteriofagów i ich zastosowania |
CN109055381B (zh) * | 2018-08-08 | 2021-12-21 | 江苏海洋大学 | 用于鳗弧菌特异性识别的ssDNA核酸适配体及筛选与应用 |
US20220008888A1 (en) * | 2018-11-22 | 2022-01-13 | Fixed Phage Limited | Production of immobilised bacteriophage |
CN112662608B (zh) * | 2021-02-04 | 2022-06-10 | 集美大学 | 一株变形假单胞菌exbB基因稳定沉默菌株及应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0209680D0 (en) | 2002-04-27 | 2002-06-05 | Univ Strathclyde | Immobilisation and stabilisation of bacteriophage |
WO2006029632A2 (en) * | 2004-09-17 | 2006-03-23 | Chr.Hansen A/S | Chimeric phage-derived particles, methods for their production and use |
MX2007005279A (es) * | 2004-11-02 | 2008-03-11 | Gangagen Life Sciences Inc | Composiciones de bacteriofagos. |
GB0526176D0 (en) | 2005-12-22 | 2006-02-01 | Blaze Venture Technologies Ltd | Particle binding |
US20140234391A1 (en) * | 2011-06-30 | 2014-08-21 | Kishore Murthy | Location-specific bacterial management |
US9504721B2 (en) | 2012-06-04 | 2016-11-29 | Ctc Bio, Inc. | Bacteriophage and its use for preventing proliferation of pathogenic bacteria |
GB201217097D0 (en) * | 2012-09-25 | 2012-11-07 | Fixed Phage Ltd | Treatment of bacterial infection |
-
2016
- 2016-04-20 WO PCT/EP2016/058809 patent/WO2016170013A1/en active Application Filing
- 2016-04-20 CN CN201680023227.5A patent/CN107743397B/zh active Active
- 2016-04-20 CA CA2983214A patent/CA2983214C/en active Active
- 2016-04-20 DK DK16720752.1T patent/DK3285787T3/da active
- 2016-04-20 PT PT167207521T patent/PT3285787T/pt unknown
- 2016-04-20 KR KR1020177033265A patent/KR20180016360A/ko not_active Application Discontinuation
- 2016-04-20 US US15/567,825 patent/US10849942B2/en active Active
- 2016-04-20 EP EP16720752.1A patent/EP3285787B8/en active Active
- 2016-04-20 ES ES16720752T patent/ES2790635T3/es active Active
- 2016-04-20 BR BR112017022463-1A patent/BR112017022463B1/pt active IP Right Grant
-
2017
- 2017-10-19 CL CL2017002668A patent/CL2017002668A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN107743397A (zh) | 2018-02-27 |
EP3285787A1 (en) | 2018-02-28 |
US10849942B2 (en) | 2020-12-01 |
CA2983214A1 (en) | 2016-10-27 |
ES2790635T3 (es) | 2020-10-28 |
EP3285787B8 (en) | 2020-06-17 |
BR112017022463B1 (pt) | 2021-10-13 |
EP3285787B1 (en) | 2020-02-19 |
US20180110812A1 (en) | 2018-04-26 |
WO2016170013A1 (en) | 2016-10-27 |
CL2017002668A1 (es) | 2019-01-11 |
CA2983214C (en) | 2023-10-17 |
BR112017022463A2 (pt) | 2018-07-17 |
KR20180016360A (ko) | 2018-02-14 |
PT3285787T (pt) | 2020-05-11 |
CN107743397B (zh) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3291679T3 (da) | Ændring af mikrobielle populationer og modificering af mikrobiota | |
DK3134530T3 (da) | Behandling af hyperbilirubinæmi | |
DK3334422T3 (da) | Anvendelse af cannabidiolsyre i behandling af epilepsi | |
DK3120831T3 (da) | Topikal levering af hudsammensætninger med lav ph | |
DK3117310T3 (da) | Håndtering af behandling associeret med valgte arkitektoniske indretninger | |
DK3778595T3 (da) | Pancreatitisbehandling | |
HK1249432A1 (zh) | 治療細菌感染的方法 | |
SG11201609652RA (en) | Treatment of polybacterials infections | |
DK3099298T3 (da) | Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner | |
DK3003307T3 (da) | Kombinationsterapi omfattende oxazolidinon-quinoloner til anvendelse i behandling af bakterieinfektioner | |
DK3307267T3 (da) | Behandling af multipel sklerose | |
DK3393579T3 (da) | Øjenbehandlingssystem | |
DK3380086T3 (da) | Cyp26-resistente rar-alpha-selektive agonister i behandling af cancer | |
DK3166911T3 (da) | Inkorporering af biologiske midler i gødning | |
DK3094322T3 (da) | Administration af tasimelteon i fastende tilstand | |
DK3373874T3 (da) | Medicinsk forbinding | |
DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
BR112018000204A2 (pt) | métodos de tratamento de colite | |
DK3102218T3 (da) | Behandling af topiske og systemiske bakterieinfektioner | |
DK3302478T3 (da) | Pac-1 kombinations behandling | |
DK3285787T3 (da) | Behandling af bakterieinfektioner i akvakultur | |
DK3342853T3 (da) | Tarmbakterier butyribacter intestini | |
DK3535511T3 (da) | Reduktion af mikrobiologisk vækst i rør | |
DK3200783T3 (da) | Behandling af erytromelalgi | |
DK3233104T3 (da) | Immunterapi-behandlinger og -sammensætninger |